Alzamend Neuro is trading 5.8% up at $1.28 today amid low-cap volatility and a lack of fresh company-specific catalysts.
- There are no new headlines or regulatory filings to explain the upward price action on an otherwise quiet news day.
- The gain appears driven by general risk-on sentiment rather than a defined event, as broader indexes show only modest gains.